The operation will be carried out by “granting preference rights to TeraPlast shareholders as of the registration date, as approved by the Extraordinary General Meeting of the Shareholders on June 27, 2024, and by the Board of Directors through Decision no. 19 of July 5, 2024”, as per the report.
TeraPlast will increase its share capital by a maximum amount of RON22.2 million, from the current value of RON217.8 million to a maximum value of RON240.1 million, by issuing a maximum number of 222.2 million new ordinary, registered shares, in dematerialized form, with a nominal value of RON0.1/share.
“The maximum subscription price at which the entitled shareholders (shareholders registered at the registration date of July 16, 2024) will be able to exercise their preferential rights, of RON 0.45/newly issued share”, the report reads.
According to the report, the number of preference rights issued is equal to the number of shares registered in the shareholder register on the registration date. A number of 9.806482259225923 preference rights are required to subscribe to one newly issued share. The subscription period for the shares offered starts on August 12, 2024, included, until September 10, 2024, included, as per the provisions of the prospectus.
“The new shares remaining unsubscribed within the Preference Period will be offered for subscription in a private placement, based on one or more exceptions from the obligation to publish a public offer prospectus”, the report also shows.
TRP shares have lost 1.75% so far in 2024 but gained 5.4% in the last 12 months, triggering a market value of RON1.1 billion.
The company’s main shareholder is businessman Dorel Goia, with a 46.8% ownership stake, followed by private pension fund Fondul de Pensii Administra Privat NN, with 12%.